CMR Surgical secures £425m in Series D financing led by SoftBank Vision Fund 2 and Ally Bridge Group to scale global operations.
The funding round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group to support international expansion and technological development.
CMR Surgical develops the Versius Surgical Robotic System, a widely adopted soft tissue surgical robot used in tens of thousands of procedures worldwide. Headquartered in Cambridge, the company works to make robotic minimal access surgery more accessible.
Cambridge-based medical technology company CMR Surgical has secured £425m in a Series D financing round. The investment was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group, with participation from several new and existing international backers.
The capital injection will be deployed to drive the accelerated global commercialisation of the company's Versius surgical robotic system and to further develop its supporting digital ecosystem. The financing values the business at $3bn following strong international demand for its portable surgical robot across multiple geographies.
From the founder
"This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion. As the lead investor, SoftBank has a wealth of experience supporting disruptive business models and innovative technologies, and we look forward to leveraging their expertise and extensive ecosystem. I would also like to thank our existing investors for their long-term support."
Per Vegard Nerseth
Chief Executive Officer at CMR Surgical
Investor perspective
"Demand for minimally invasive robotic surgery is growing rapidly among surgeons and patients yet high costs have historically hindered adoption."
Yanni Pipilis
Managing Partner, SoftBank Vision Fund 2
Use of funds
- 01Expand into international markets
- 02Continue product development
Investors
.png)
Yanni Pipilis
SoftBank Vision Fund 2
Charles Chon
Ally Bridge Group
RPMI Railpen
Tencent
Chimera
Lightrock
Watrium
Cambridge Innovation Capital
PFM Health Sciences
GE Healthcare
Categories
About the company
CMR Surgical
CMR Surgical manufactures the Versius system for robotic minimal access surgery.